Back to News
Market Impact: 0.2
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?
Source: zacks.com
Analyst EstimatesMarket Technicals & FlowsHealthcare & Biotech
CareDx shares rose in the latest session on above-average trading volume, indicating increased investor activity. However, recent earnings-estimate revisions do not support expectations for continued upside, creating a cautious near-term outlook for CDNA.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
CDNA-0.30
More News
- Bond market alarms are ringing on Wall Street. Here's what's ahead
- Warsh's regime change at the Fed pushes ahead – and meets resistance
- Wall Street Week | China’s Trade Reckoning, Syracuse’s Second Chance, Humanoids in Healthcare
- Chartstopper: September 25, 2026
- Oil Prices Decline on Hopes of a Hormuz Deal
- Bond Selloff Fades, US-Iran Said to be Exploring Phased Deal, Trump-Xi Summit